- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: L.30, T.69, I.71, R.94, F.95, P.96
- Ligands: ANP.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.94
EDO.4: 5 residues within 4Å:- Chain A: D.265, Y.266, E.267, R.268
- Chain B: Y.127
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.265, A:E.267, A:R.268
EDO.8: 7 residues within 4Å:- Chain B: L.30, T.69, I.71, R.94, F.95, P.96
- Ligands: ANP.6
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.94
EDO.9: 5 residues within 4Å:- Chain A: Y.127
- Chain B: D.265, Y.266, E.267, R.268
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.265, B:E.267, B:R.268
- 2 x 7DQ: 6-(4-{[4-(propan-2-yl)phenyl]acetyl}piperazin-1-yl)pyridazine-3-carbonitrile(Non-covalent)
7DQ.5: 21 residues within 4Å:- Chain A: E.146, G.201, V.202, S.203, R.215, G.218, T.219
- Chain B: V.258, I.261, Y.266, L.271, V.276, A.277, N.307, G.310, S.311, R.314, A.345, L.346, W.349
- Ligands: ANP.1
10 PLIP interactions:7 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:V.258, B:I.261, B:Y.266, B:L.271, B:A.345
- Hydrogen bonds: B:R.314, A:R.215, A:R.215
- pi-Stacking: B:W.349
- pi-Cation interactions: A:R.215
7DQ.10: 21 residues within 4Å:- Chain A: V.258, I.261, Y.266, L.271, V.276, A.277, N.307, G.310, S.311, R.314, A.345, L.346, W.349
- Chain B: E.146, G.201, V.202, S.203, R.215, G.218, T.219
- Ligands: ANP.6
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:V.258, A:I.261, A:Y.266, A:L.271, A:A.345
- Hydrogen bonds: A:R.314, B:R.215, B:R.215
- pi-Stacking: A:W.349
- pi-Cation interactions: B:R.215
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sharma, L.K. et al., A therapeutic approach to pantothenate kinase associated neurodegeneration. Nat Commun (2018)
- Release Date
- 2018-08-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x 7DQ: 6-(4-{[4-(propan-2-yl)phenyl]acetyl}piperazin-1-yl)pyridazine-3-carbonitrile(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sharma, L.K. et al., A therapeutic approach to pantothenate kinase associated neurodegeneration. Nat Commun (2018)
- Release Date
- 2018-08-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A